TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and ...
TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...
TUCSON, Ariz., July 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to ...
TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate WAVE™ ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Accelerate Diagnostics has filed ...
Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public offering of 6,860,659 units at $1.50 each. Up Next: Get 5 Dark Horse Stocks ...
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Accelerate Diagnostics, Inc. (“Accelerate ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shares of Accelerate Diagnostics ...
Today is shaping up negative for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. There was a fairly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results